Concepedia
Statistics
Publications
13
Citations
769
H-Index
Active since
1989
Affiliations
Biogen (United States)(Current)
Johns Hopkins University
Dnipro State Medical University
University of Milan
General University Hospital in Prague
Karen R. McLachlan is an author at Biogen (United States) specializing in life sciences, pharmacology, and medicine.
Publications per year
1989–2025
A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral γ-Secretase Inhibitor PF-03084014
Wells A. Messersmith, Geoffrey I. Shapiro, James M. Cleary et al. · Clinical Cancer Research · 2014 · 215 citations · Full text
Medicine, Oncology, Pharmacology +17
Novel Insights on Human NK Cells’ Immunological Modalities Revealed by Gene Expression Profiling
Jacob H. Hanna, Pamela E. Bechtel, Yufeng Zhai et al. · The Journal of Immunology · 2004 · 163 citations · Full text
Life Sciences, Cell Biology, Immunology +17
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study
Giovanni Martinelli, Vivian G. Oehler, Cristina Papayannidis et al. · The Lancet Haematology · 2015 · 109 citations
Medicine, Pharmacokinetics, Pharmacology +7
A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors
Andrew J. Wagner, Wells A. Messersmith, M. Naveed Shaik et al. · Clinical Cancer Research · 2014 · 66 citations
Medicine, Oncology, Pharmacology +16
Substrate specificity of <i>N</i>-acetylglucosamine 1-phosphate transferase activity in Chinese hamster ovary cells
Karen R. McLachlan, Sharon S. Krag · Glycobiology · 1992 · 36 citations
Life Sciences, Biochemistry, Molecular Biology +17
1–5 of 13